Elevation Oncology, Inc. Business Finance Contracts & Agreements
13 Contracts & Agreements
- Investor Rights Agreements (1 contract)
- Loan Agreements (2)
- Participation Agreements (1)
- Purchase Agreements (1)
- Stock Agreements (2)
- Underwriting Agreements (2)
- Warrant Agreements (4)
- First Amendment to Loan and Security Agreement, dated March 1, 2024, by and among the Company, the lenders, and K2 HealthVentures LLC, as administrative agent (Filed With SEC on May 2, 2024)
- Warrant to Purchase Common Stock, issued March 1, 2024, to K2 HealthVentures Equity Trust LLC (Filed With SEC on May 2, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on June 9, 2023)
- Form of Purchase Warrant (Filed With SEC on June 9, 2023)
- Underwriting Agreement dated June 8, 2023 (Filed With SEC on June 9, 2023)
- Loan and Security Agreement, dated July 27, 2022, by and among the Company, the lenders, K2 HealthVentures LLC, as administrative agent, and Ankura Trust Company, LLC, as... (Filed With SEC on November 3, 2022)
- Warrant to Purchase Common Stock, issued July 27, 2022 to K2 HealthVentures Equity Trust LLC (Filed With SEC on November 3, 2022)
- 2021 Employee Stock Purchase Plan, to become effective on the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on June 21, 2021)
- Form of Common Stock Certificate (Filed With SEC on June 21, 2021)
- Form of Underwriting Agreement (Filed With SEC on June 21, 2021)
- Form of IPO Participation Right Letter (Filed With SEC on June 4, 2021)
- Asset Purchase Agreement dated May 28, 2019, by and between the Registrant and Merrimack Pharmaceuticals, Inc., as amended (Filed With SEC on June 4, 2021)
- Amended and Restated Investors Rights Agreement, dated November 10, 2020 by and among Elevation Oncology, Inc. and certain of its stockholders (Filed With SEC on June 4, 2021)
